WORK Medical Technology Group Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy
Stocks in this Quantisnow insightHealth Care
Historical context for WOK
Across the 6 sessions after earlier WOK headlines, the stock closed higher 5 times and lower 1 times, with a median move of 17.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | WOK | SPY |
|---|---|---|---|
| May 11, 2026 | WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the "BioToken" Assetization Model | +206.3% | +0.2% |
| May 1, 2026 | WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper | +6.6% | +0.3% |
| Dec 29, 2025 | WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026and 1 other headline that session | +24.0% | -0.4% |
| Dec 24, 2025 | WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025 | -32.9% | +0.4% |
| Nov 4, 2025 | WORK Medical Technology Group LTD's Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation | +11.3% | -1.2% |
| Oct 21, 2025 | WORK Medical Technology Group LTD Announces US$1 Million Equity Investment in Neologics Bioscience | +9.2% | -0.0% |
Quantisnow market dataNASDAQ
WOK
WORK Medical Technology Group LTD
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2024
Get push alerts for WOK
Full WOK profile on Quantisnow Follow WOK and get a push notification the moment its next story breaks.